Regulation of TGF-β Family Signaling by Inhibitory Smads
Open accessThe DOI matches its Crossref record; 210 of the 211 references it cites were found in a registry or an index.
Abstract
Inhibitory Smads (I-Smads) have conserved carboxy-terminal MH2 domains but highly divergent amino-terminal regions when compared with receptor-regulated Smads (R-Smads) and common-partner Smads (co-Smads). Smad6 preferentially inhibits Smad signaling initiated by the bone morphogenetic protein (BMP) type I receptors ALK-3 and ALK-6, whereas Smad7 inhibits both transforming growth factor β (TGF-β)- and BMP-induced Smad signaling. I-Smads also regulate some non-Smad signaling pathways. Here, we discuss the vertebrate I-Smads, their roles as inhibitors of Smad activation and regulators of receptor stability, as scaffolds for non-Smad signaling, and their possible roles in the nucleus. We also discuss the posttranslational modification of I-Smads, including phosphorylation, ubiquitylation, acetylation, and methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RAB11 285, which is responsible for endosomal recycling of TGFβ receptors 286, is recruited to the cilium in a process that is mediated by the subdistal appendage protein, CEP128 287. Consequently, loss of CEP128 leads to impaired phosphorylation of R-SMADs, which in zebrafish is associated with defective organ development 287.”
From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [287]
In the citing paper
“Also, non-mutational mechanisms impair the growth inhibitory response to TGF-β. In advanced tumors, TGFBR2 or SMAD2 genes are frequently silenced by histone and DNA methylation122,123. Additionally, increased inhibitory Smad6 or Smad7 expression in various carcinomas, including PDAC, attenuates Smad signaling124,125, whereas increased expression of the Smad corepressors c-Ski or SnoN, observed in”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [124]
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857 · cited 1×
“TGF-b family ligands trigger signaling through hetero-oligomerization of two types of transmembrane receptors with intrinsic serine-threonine kinase activities: the type I and type II receptors (Shi and Massagué 2003).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundNon-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749 · cited 1×
“…# 2017 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a022095 Cite this article as Cold Spring Harb Perspect Biol 2017;9:a022095 1 tivated receptors can transmit signals independent of Smad proteins (non-Smad signaling pathways) (Zhang 2009).”
BackgroundInfluentialIdentification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundHayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSMAD proteins control DROSHA-mediated microRNA maturation
Davis, B. N., Hilyard, A. C., Lagna, G., & Hata, A. (2008) · Nature · doi:10.1038/nature07086 · Cited by 1,244 · cited 1×
“Activated Smad proteins promote the maturation of miR-21 independent of Smad4 by associating with the stem region of pri-miR-21 (Davis et al. 2008).”
BackgroundSmad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205 · cited 1×
“2A) (Kavsak et al. 2000; Ebisawa et al. 2001; Murakami et al. 2003).”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundFantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135 · cited 1×
“3), leading to enhanced TGF-b signaling and acquisition of regulatory properties by these cells, including an antiproliferative effect on CD4þ T cells (Fantini et al. 2004).”
BackgroundSmad6 inhibits signalling by the TGF-β superfamily
Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J.-I., Kawabata, M., & Miyazono, K. (1997) · Nature · doi:10.1038/39355 · Cited by 1,029 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSelf-citation
Research works printed but not linked: 1
- 10.1172/jci200112367 · doi:10.1172/jci200112367 · Paper page
Cited by
Items 401–463 of 463
Yu, J., Dong, Y., Tang, W., Pan, H., Lv, L., Long, T., Zhou, Q., Qi, J., Liu, J., Ding, G., et al. (2020) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s250076
“A subgroup of inhibitory SMADs (I-SMADs, including SMAD6, −7) attenuates the signaling by competing with the R-SMADs for TGF-β receptors or directly interacting with R-SMADs.(1,3,4) Drugs that mediate the TGF-β signaling pathway have shown increasing potency of changing the current treatment of various cancers.”
BackgroundThe anti-colitic properties of hookworm protein Na-AIP-1
Buitrago, G. (2020) · ResearchOnline - JCU (James Cook University) · doi:10.25903/va6s-6046
(2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88433-4.00008-5
Omi, M., & Mishina, Y. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62213-4
Epithelial-Mesenchymal Interactions Between Hair Follicles and Dermal Adipose Tissue
Ramos, R., & Plikus, M. V. (2022) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-98331-4_6
Investigating the Proliferation-Quiescence Decision in Tissues and in Cancer Cells
Pulianmackal, A. J. (2022) · Deep Blue (University of Michigan) · doi:10.7302/4770 · Cited by 1
Effects of TGF-β and IL-6 on the Development and Metastasis of Gastric Cancer
王, 英. (2022) · Medical Diagnosis · doi:10.12677/md.2022.121011
Sun, Q., Kang, Y., Liu, Y., Zhang, Y., Wang, Y., Tan, X., & Zhang, M. Q. (2024) · Research Square · doi:10.21203/rs.3.rs-3871020/v1
Computational analysis in epithelial tissue regeneration
Chhabra, P., & Gandhi, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13222-3.00024-1
Rossi, M. (2022) · theses.fr (ABES) · doi:10.70675/dcf7233ez1236z4ef5z9b12za9d9cd26166b
Naik, A. S. (2020) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/8meg-hs6m
Role and therapeutic potential of the NEDD4 family in breast cancer
Zhang, X., & Li, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1587675
Spermine: A prospective treatment for high glucose-induced myocardial fibrosis in db/db mice.
Liu, Y., Liu, X., Li, S., Xu, T., Lü, Y., Wang, T., & Yuan, H. S. (2025) · PubMed Central · doi:10.22038/ijbms.2025.83464.18060
“It plays an important role in promoting the transformation of myocardial fibroblasts into myofibroblasts, transmitting biological signals to the nucleus to activate collagen I and collagen III gene expression, regulating the MMP/TIMP system, and affecting ECM homeostasis (23, 24).”
Mladenović, T., Matić, S. L., Pavić, J., Virijević, K. D., & Filipović, N. (2025) · Lecture notes in networks and systems · doi:10.1007/978-3-031-99201-8_33
Yoshigi, M., Kamdem, S. D., Wang, H., Khambete, A., Sprouse, F., Kameni, E. M., Atiogue, E., Pellizzari, S., Evason, K. J., Helms, M. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.19.688968
Wang, J., Tao, J., Xia, C., Tang, M., Stoica, A.-F., Yuan, S., Li, Y., Guo, L., Kong, X., & Wang, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.25.690307 · Cited by 1
Adianingsih, O. R., Latifani, S., Fitriani, A. N., Wardani, A. D., Qurrotuain, I., Wahyudi, R. T., Dewi, A. M. P., Dhinata, J. A. W., Rumabutar, G. A., Puspita, O. E., et al. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e174188 · Cited by 1
Xiao, P., Zhu, Z., Du, C., Zeng, Y., Liao, J., Cheng, Q., Chen, H., Zhao, C., & Huang, W. (2021) · Figshare · doi:10.6084/m9.figshare.14037860
Huang, W., Zhang, Z., Li, X., Zheng, Q., Wu, C., Liu, L., Chen, Y., Zhang, J., & Jiang, X. (2024) · Figshare · doi:10.6084/m9.figshare.27124063
Wei, E., Hu, M., Wu, L., Pan, X., Zhu, Q., Liu, H., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25939972
SMAD6 balances BMP signaling in endothelial cells to promote vascular development and function
Kulikauskas, M. R. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/f7ak-sj17
Huang, W., Zhang, Z., Li, X., Zheng, Q., Wu, C., Liu, L., Chen, Y., Zhang, J., & Jiang, X. (2024) · Figshare · doi:10.6084/m9.figshare.27124066
Developmental regulation of Drosophial Dad, the inhibitory SMAD for the TGFβ signaling pathway
Soares, A. R. D. S. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/8avy-wq15
Martel, P.-O. (2024) · Le dépôt institutionnel (Université du Québec à Trois-Rivières)
Hibernation vs. hypoxia: an underlying epigenetic, microRNA, and signaling framework
Ingelson-Filpula, A. (2025) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2025-16788
Osman, W. A., Selmy, A., Mahmoud, F. A., Elwahab, N. G. A., Faisal, S., Lashine, R. M., Mohammed, M. Y., Mahmoud, A. K., Algohary, S. A., Elaidy, S. M., et al. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-00934-7
Research Progress on the Regulation of Pulmonary Hypertension by the NOTCH3 Signaling Pathway
Huang, Z., Deng, Y., Zeng, J., Li, D., & Zhang, Y. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001107
Tissue-specific I-Smad mechanisms revealed by structure–function analysis in Drosophila
Simoncek, A. M., Sviridoff, S., Hays, J. N., Graichen, N. J., & Sulkowski, M. J. (2026) · Life Science Alliance · doi:10.26508/lsa.202503445
“**Submission of a paper that does not conform to Life Science Alliance guidelines will delay the acceptance of your manuscript.** **It is Life Science Alliance policy that if requested, original data images must be made available to the editors.”
Bao, L., Li, L., Tang, S., Tang, Y., Wang, Z., Tan, J., Zhang, H., Liu, R., & Zhang, X. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl53953
Clément, F. (2017) · theses.fr (ABES) · doi:10.70675/84d5cd50z20d4z4df2z9292z1a331860bebf · Cited by 1
The transgenic Drosophila HLA-B27 : a new model for the study of spondyloarthritis
Grandon, B. (2018) · theses.fr (ABES) · doi:10.70675/e73e63dezb0b7z4e75z8393zff5ae78924a2
“Les R-Smad possèdent à leur extrémité C-terminale une séquence SSXS (sérine-sérine-X-sérine), qui correspond au site de phosphorylation par les récepteurs de type I. Les protéines R-Smad, phosphorylées et activées, forment des complexes avec Smad-4 et se déplacent vers le noyau.”
BackgroundInfluentialEtude de l'implication des acides sialiques dans la régulation de la fusion myoblastique
Vergé, C. (2019) · theses.fr (ABES) · doi:10.70675/fe311d0ez459cz4ffdzbc44z2352ab57a4cd
Effet du TGFβ produit par le microenvironnement sur les tumeurs du pancréas exocrine
Cardot‐Ruffino, V. (2019) · theses.fr (ABES) · doi:10.70675/5a044019zf697z4071z9643zee4c85ba364f
Le rôle de GDF11 dans les leucémies aiguës myéloïdes
Siavellis, J. (2021) · theses.fr (ABES) · doi:10.70675/b953e730zc0bez4347za9e4z561daebbcc2d
Initial molecular steps of bone regeneration : cellular scale modulation
Khodr, V. (2021) · theses.fr (ABES) · doi:10.70675/60d6c391z18a7z477fz845czee98026f5234
Bertrand‐Chapel, A. (2021) · theses.fr (ABES) · doi:10.70675/6f1078b7z94d3z4096z85a9z40b435cd6a59
Tarrass, M. A. (2023) · theses.fr (ABES) · doi:10.70675/aea61e27z0cadz4558za7acz92d960d99b81 · Cited by 1
Dong, X., Wang, Y., Li, Y., Wang, X., Yu, Q., Han, C., Wang, J., Liu, S., Wu, J., & Liu, S. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1780630
“…selected electrospinning technology to prepare electrospun nanofiber membranes as physical barriers for implantation (Tan et al., 2025; Humeres et al., 2024; Miyazawa and Miyazono, 2017; Wang et al., 2014; Yong et al., 2024; Chen et al., 2025; Cai et al., 2025; Ma et al., 2025; Tarin et al., 2025).”
Jasper, E. A., McKennan, C. G., Thompson, E. E., Schoettler, N., Gebretsadik, T. S., Hellwege, J. N., Edwards, T. L., Ober, C., Edwards, D. R. V., Hartert, T. V., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-51718-1
“SMAD6 plays a critical role in immune regulation, primarily by suppressing pro-inflammatory signaling pathways 39 .”
zDHHC21 loss of function activates lung fibroblasts by regulating PTEN palmitoylation
Bieerkehazhi, S., McDowell-Sanchez, A. K., Akimzhanov, A. M., & Tsoyi, K. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag097
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Fibrosis and Cancer
Amengual, J., Espinosa‐Sotelo, R., Cantos‐Cortes, A., Gonfaus-Ortiz, G., Alay, A., Campuzano, V., Egea, G., Bertrán, E., & Fabregat, I. (2026) · Springer eBooks · doi:10.1007/978-3-032-21135-4_21
Biswas, T., Chongtham, C., Kumari, N., Saneja, Y., Yadav, N. K., Maras, J. S., Kamat, S. S., & Arimbasseri, G. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.10.731289
Cartilage intermediate layer protein (CILP) in cardiac fibrosis: Protective or pathogenic?
Corrales-Terrón, M., Rossi, C., Krause, J., Schroen, B. L. M., Herum, K. M., & van Nieuwenhoven, F. A. (2026) · Matrix Biology · doi:10.1016/j.matbio.2026.102032
Decoding the secretory blueprint of bone healing: from gradients to regeneration
Yang, W., Wang, Y., Liu, K., Zhao, Y., & Wang, W. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1873387
“…expression levels of I-Smads have been associated with conditions such as osteosclerosis and heterotopic ossification, underscoring their potential as therapeutic targets in bone regeneration (Zou et al., 2021; de Ceuninck van Capelle et al., 2020; Fang et al., 2016; Miyazawa and Miyazono, 2017).”
Interplay between growth factor signaling and epigenetic landscapes in stem cell stemness
Patra, S. K., Gurjar, D., Saha, B., & Lenka, N. (2026) · Cytokine · doi:10.1016/j.cyto.2026.157188
Hunting gremlins: GREM1 as a new therapeutic target for multiple diseases including glaucoma
Siderovski, D. P., Myneni, N., Botross, M., Patel, P. D., & Clark, A. F. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100152
E3 Ubiquitin Ligase Mind Bomb 1 is a Novel Negative Regulator of Tumor-Suppressive BMP Signaling
Cottonham, C., Hernandez, G. E., Cheung, T. K., Rose, C. M., Srinivasan, R., Piskol, R., Yao, X., & Siebel, C. W. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0760
“Ligand availability and receptor binding are modulated by various factors such as extracellular antagonists, glycoproteins, extracellular matrix proteins, and decoy receptors (5–7).”
Smad3 deficiency attenuates disease severity in a zebrafish model for Smad6-related aortic disease
Vanhooydonck, M., Verlee, M., Silva, M. S., Pottie, L., Boel, A., Impe, M. V., Saffel, H. D., Caboor, L., Bonnin, A., Segers, P., et al. (2026) · Angiogenesis · doi:10.1007/s10456-026-10051-x
“I-SMAD6 primarily suppresses the pathway activated by the BMP-receptor, whereas I-SMAD7 inhibits both the TGFβ and BMP induced pathways [ 9].”
Amano, H., Komuro, A., Ota, K., Honda, M., Sakai, K., Nishio, K., Ueda, T., & Okada, H. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102752
Nemshick, M., Oxman, E., & Leon, E. L. (2026) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.70294
Nasser, M. I. (2026) · Archives of Medical Science · doi:10.5114/aoms/224767
Research Progress on Signaling Pathways in Breast Cancer Bone Metastasis
Li, Y., Li, T., Liang, F., Kuang, L., Li, Y., & Li, H. (2026) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2026.079898
Auerbach, B. J., Lordan, R., Tang, S. Y., Hennessy, E., Anderson, S. T., Das, U. S., McConnell, R., Li, M., & FitzGerald, G. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.03.749170
Soejima, Y., Yamamoto, K., Iwata, N., Motohashi, K., Suyama, A., Nakano, Y., & Otsuka, F. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154591
FKBP12 determines ligand-specific SMAD signaling in individual living endothelial cells
Huang, Z., Lenhardt, S., Snyder, P., Bulldan, A., Hausch, F., & Loewer, A. (2026) · iScience · doi:10.1016/j.isci.2026.117728
“17 Collectively, these elements shape the dynamics of SMAD activity and influence endothelial cell fate decisions.”
Metadata
- Authors
- Miyazawa, K., & Miyazono, K.
- Affiliations
- University of Yamanashi (JP)
- The University of Tokyo (JP)
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-12-05
- Volume
- 9
- Issue
- 3
- Pages
- a022095
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC5334261
- OpenAlex
- W2560615789
- Cited by
- 439
- References
- 211
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 43 · 2023: 56 · 2022: 61 · 2021: 78 · 2020: 56 · 2019: 33 · 2018: 32 · 2017: 19 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (15H05774)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- inhibitory Smads, Smad6, Smad7, TGF-beta signaling, BMP signaling, Smad activation, receptor stability, non-Smad signaling, post-translational modification, phosphorylation, ubiquitination, acetylation, methylation
- MeSH terms
- Animals, Humans, Protein Conformation, Protein Processing, Post-Translational, Signal Transduction, Transforming Growth Factor beta, Smad Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.